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Modulation of glomerular proteoglycans by insulin-like growth
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Modulation of glomerular proteoglycans by insulin-like growth fac-
tor-i. Effect of insulin-like growth factor-I (IGF) on the synthesis of
glomerular proteoglycans (PGs) in an ex vivo recirculating organ
perfusion system was investigated. Kidneys were perfused with a
medium (--80 ml) containing [35S]-sulfate (250 Ci/ml) and IGF (62.5 to
625 nglml). After radiolabeling, a small cortical piece was saved for
tissue autoradiography, and the remaining kidney and the perfusion
medium were utilized for biochemical studies. The glomeruli were
isolated; their PUs extracted and characterized. A two- to threefold
increase of the total radioactivities in tissue and media fractions was
observed with the exposure to IUF. By Sepharose CL-6B chromatog-
raphy, the tissue PGs eluted as two peaks (A and B) with Kay 0.24
and 0.48, and the majority of the radioactivity was confined to peak A.
This peak contained intact PUs while peak B included glycosaminogly-
can (GAG) chains. Elution profiles of the glomerular PGs were similar
in the control and IUF groups. However, there was a disproportionate
increase of chondroitin/dermatan sulfate in the IGF group. The media
fractions also had two peaks, and most of the radioactivity was
associated with peak B containing GAG chains. A remarkable accen-
tuation of peak B along with significant increase in the chondroitin/
dermatan sulfate were observed in the IUF group. By DEAE-Sephacel
chromatography, the PUs/GAGs of IGF group eluted at a relatively
lower salt concentration as compared to the control. Autoradiography
revealed a relatively high concentration of radioactivity over the
mesangium as compared to the other cell types of the glomerulus.
[35S1-methionine studies revealed a generalized increase of protein
synthesis in the IGF group, but comparatively much less than that of
PUs/GAGs. These results indicate that IGF enhances the biosynthesis
of PGs/GAGs by various cell types of the renal glomenilus, especially
that of the mesangial cell, as reflected by the selective increase of
chondroitin/dermatan sulfate.
Insulin-like growth factor-i (IGF-1) is a single polypeptide
chain (Mr —7,600) whose protein sequence and diverse biolog-
ical activities are similar to those of insulin [1—6]. Its biological
effects are mediated via specific plasmalemmal receptors
present on a wide variety of cells, including those of renal
glomeruli and tubules [7—9]. The presence of these receptors on
renal mesangial cells has led several investigators to believe
that IGF-l may play a role in renal hypertrophy in diabetes and
after partial renal ablation, perhaps by modulating the metabo-
lism of various glycoproteins of the extracellular matrix (ECM)
[10—13].
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The glomerular ECM, comprised of mesangial matrix (MM)
and glomerular basement membrane (GBM), consists of several
glycoproteins: type IV collagen, laminin, entactin and proteo-
glycans [14-17]. Several studies have delineated the derange-
ments in the metabolism of one or more glycoproteins of the
ECM in diabetic nephropathy 118, 19]. The latter is accompa-
nied by the expansion of the mesangium and thickening of the
GBM. The biochemical abnormalities related to these renal
morphological lesions seem to reside in the collagenous and
proteoglycan components of the ECM [20, 211. In this regard, a
decrease in the biosynthesis of proteoglycans has been reported
in both experimental and clinical diabetic states [21—24]. Inci-
dentally, these changes in the ECM are presumed to lead to a
proteinuric response observed in diabetic nephropathy [25].
Along with the changes in the ECM composition, the IGF-1
concentrations have been shown to increase in certain target
tissues, that is, retina and kidney [12, 261. Thus, it is conceiv-
able that the IGF-1 or insulin modulates the metabolism of some
of the glycoproteins of the ECM which leads to defective
cell-matrix interactions and ultimately to the evolution of char-
acteristic morphologic lesions seen in diabetic nephropathy
[27].
Little is known about the influence of IGF- 1 on the metabo-
lism of ECM components, particularly of the proteoglycans. So
far the information available in the literature pertains to cul-
tured chondrocytes [28, 29]. The influence of IGF-l on the
metabolism of renal proteoglycans is unknown. In this investi-
gation, we studied the effect of IGF-1 on the biosynthesis of
proteoglycans by various cell types of the glomerulus.
Methods
Radiolabelling of the proteoglycans
An ex vivo organ perfusion system was utilized for radiola-
beling of renal proteoglycans [15, 30, 311. Rationale for using
this system was to "mimic" the in vivo conditions while
excluding the effects of various growth factors or hormones,
circulating in the blood, on the kidney. This system also
overcame the inherent difficulties in the interpretation of the
biosynthetic data obtained from various cell or glomerular
culture experiments where a change in the phenotypic expres-
sions was observed [32].
The right kidney of 250 g male Sprague-Dawley rats was
isolated from the systemic circulation. The renal artery was
cannulated, blood was flushed out of the kidney with oxygen-
ated KRB-buffer containing 7.5% BSA, and the kidney was
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Table 1. Total incorporated [35S]-sulfate radioactivity in tissue and
media fractions
IGF
concentration
nglml
Glomerular°
(N = 5)
Mediab(N = 5)
0 7.83 0.58 6.49 0.73
62.5 9.16 0.47° 9.84 0.78°
125 10.31 0.35° 12.12 090d
375 12.94 068d 15.73 O.9S
625 16020•79d 18.29 1.02"
Data are presented as means SD.
° The counts are given as iO DPM in glomeruli isolated from one
kidneyb The counts represent io DPM per ml of the perfusion medium
P < 0.01
d <0.001
connected to a recirculating organ perfusion system. The per-
fusion medium (—80 ml) consisted of modified Krebs-Ringer
bicarbonate (KRB) solution containing a mixture of amino
acids, 10 m'vi D-glucose and 7.5% bovine serum albumin. The
perfusion was carried out for nine hours under well-oxygenated
and isothermic conditions. [35S]-sulfate (NEN Products, Bos-
ton, Massachusetts, USA) with a specific activity >1000 Ci!
mmol was included in the perfusion medium at a concentration
of 250 Ci/ml to label the proteoglycans. The final inorganic
sulfate and glucose concentrations were adjusted to 50 j.M and
7.5 mrvi, respectively. Varying concentrations of human recom-
binant IGF-1 (62.5 to 625 nglml; Amgen Biologicals, Thousand
Oaks, California, USA) was added to the perfusion medium to
ascertain its effect on the biosynthetic profiles of the proteogly-
cans. At the end of the nine-hour labelling period, the kidneys
were perfused with KRB-buffer containing 7.5% BSA for 15
minutes. A small (1 x 4 mm) cortical biopsy was performed and
processed for tissue light and electron microscopic autoradiog-
raphy. The kidneys were then flushed with Hank's balanced salt
solution containing 1% BSA, a mixture of protease inhibitors (5
mM benzamidine-HCI, 1 mi phenylmethylsulfonyl fluoride, 100
mM 6-aminohexanoic acid and 10 ms'i N-ethylmaleimide) and 50
mM EDTA. Following that, they were bisected, their cortices
dissected out and frozen at —20°C. The perfusion medium was
also saved after the addition of protease inhibitors for isolation
and characterization of proteoglycans (PGs) and glycosamino-
glycans (GAGs).
Isolation of glomeruli and extraction of proteoglycans
Frozen cortices were thawed and glomeruli isolated by the
sieving technique in the presence of protease inhibitors at 4°C.
The glomerular PGs were extracted with 10 volumes of 4 M
GuCI solution containing 10 m sodium acetate, 50 mrvt EDTA,
0.1% CHAPS and a mixture of protease inhibitors, pH 5.8 [15,
31]. Extraction was carried out by rigorous continuous stirring
for 48 hours at 4°C. The unextracted fraction was collected as a
sediment by centrifugation at 10,000 rpm for 15 minutes. The
sediment was hydrolyzed with 0.5 N NaOH at 45°C for three
hours to extract the remaining incorporated radioactivity in the
glycosaminogly cans. Aliquots of both the extracts were applied
to Sephadex G-25 (Pharmacia Inc., Piscataway, New Jersey,
USA) column equilibrated with the elution buffer [4 M GuCl, 0.1
M Tris-HCI, 0.1 M Na2SO4, 0.5% (vol/vol) Triton X-lOO, pH
7.0), and the total incorporated radioactivity in the excluded
fractions was determined. Finally, the mean radioactivity and
standard deviation about the mean were determined of the data
obtained from five separate experiments per variable.
The remaining extracts were dialyzed successively against
0.15 M NaC1 containing a mixture of protease inhibitors and
ice-cold distilled water. Subsequently, aliquots were prepared,
lyophilized and stored at —20°C.
Characterization of extracted glomerular proteoglycans
The characterization of PGs was carried out by Sepharose
CL-6B and DEAE-Sephacel chromatographies (Pharmacia,
Inc.) as detailed in our previous publications [15, 31]. Some of
the lyophilized aliquots were either digested with chondroiti-
nase-ABC (Miles Laboratories, Naperville, Illinois, USA) or
with purified heparitinase (Sigma Chemical Co., St. Louis,
Missouri, USA) as previously described [33]. The lyophilized
aliquots were reconstituted with 150 1.d of 4 M GuC1 and applied
to Sepharose CL-6B columns (100 x 0.9 cm), equilibrated with
the same elution buffer used for Sephadex G-25 chromatogra-
phy. Vo (void) and Vt (total) volumes of Sepharose CL-6B
column were determined by employing [3H]-serine cartilage
monomer proteoglycans and [3H]-serine, respectively. After
application of the reconstituted extracts to the column, the
radioactivity in the eluted fractions was measured, following
which the chromatographic profiles of the untreated and enzy-
matically-treated PGs were prepared. The molecular weights of
the glomerular PGs were estimated by interpolation of the data
obtained from tryptic-chymotryptic digests of cartilage proteo-
glycans [34].
DEAE-Sephacel columns were prepared in disposable sero-
logical pipettes with a bed volume of 2 ml, and equilibrated with
elution buffer containing 8 M urea, 0.1 M NaC1, 0.05 M sodium
acetate and 0.1% CHAPS, pH 6.0. The lyophilized samples
were reconstituted with the elution buffer and applied to the
DEAE-Sephacel column. Elution was carried out with the same
buffer containing a continuous gradient of 0.1 NI to 1.0 NI NaCI,
and effluent fractions were collected and radioactivity deter-
mined.
Isolation and characterization of glomerular
glycosaminoglycans
Glycosaminoglycans (GAGs) were prepared from the lyoph-
ilized tissue proteoglycans by alkaline hydrolysis with 0.5 N
NaOH at 45°C for three hours. The hydrolysates were dialyzed
against ice-cold distilled water, aliquots prepared and lyophi-
lized. The characterization was carried out by Sepharose
CL-6B chromatography before and after treatment with hepar-
itinase or chondroitinase-ABC as previously described [331.
The molecular weights of the GAG chains were estimated by
comparing the peak elution positions with the values obtained
by Wasteson for chondroitin sulfate [35].
Isolation and characterization of media
proteoglycans/glycosaminoglycans
Aliquots of 0.5 ml were applied to Sephadex G-25 column,
the excluded fractions collected, pooled and total incorporated
radioactivity in the media determined. The media PGs/GAGs
from the excluded fractions were characterized by Sepharose
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Fig. 1. Sepharose CL-6B chromatograms of
f35SJsulfate-labelled proteoglycansi
glycosaminoglycans extracted from glomeruli
of control and IGF-treated kidneys. In control
(panel A), the intact (original, —0—) PGs
eluted as 2 peaks (A and B) of radioactivity.
Treatment with heparitinase (--fl--) and
chondroitinase-ABC (C-ABC, —•—--) resulted
in the release of -93% and --7% of the
radioactjvjties into the Vt fraction,
respectively. In the 1GF-group, the elution
profiles of PGs/GAGs were similar to control
but a greater amount of radioactivity (-26%)
was released into the Vt fraction with the
treatment of chondroitinase-ABC.
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CL-6B and DEAE-Sephacel chromatographies before and after
digestion with chondroitinase-ABC or heparitinase as described
above.
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Experiments with [35S]-methionine
These studies were carried out to ascertain the effect of IGF-l
on generalized protein synthesis. The rat kidneys were radio-
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partment was computed by the point counting method [37],
utilizing a transparent overlay of a network of points spaced 1.0
cm apart. The number of intersections over a given compart-
ment represents its relative area. The area occupied by the
nucleus was excluded in these determinations. Then, total
number of grains were counted on each compartment by the
best-fit circle method [381. Finally, the grain density (concen-
tration of radiation) was calculated by dividing the grain count
by total number of intersections. The data from control and
IGF- 1 groups of various autoradiographic and biochemical
studies were statistically analyzed by Student's t-test.
Results
Incorporation of [35S]-su!fate into tissue and media fractions
Fig. 2. Effect of various concentrations of !GF-1 on the synthesis of
[35SJ-labelled total PGs (glomerular + media; ), HS-PG () and
CS/DS-PG (U). Maximal effect was observed in CS/DS-PG fraction at
all concentrations of IGF used. N = 5.
labelled with inclusion of [35S]-methionine (10 Ci/ml) and
IGF-1 (375 ng/ml) in a modified medium of the organ perfusion
system as described above. The modification included exclu-
sion of the methionine from the medium. After nine hours of
radiolabeling, a small cortical biopsy was performed and the
remaining kidneys were processed for isolation of glomeruli,
and extraction of proteins and proteoglycans as detailed above.
Free [35S]-methionine was removed by passing the extracts
through Sephadex G-25 column and total incorporated radioac-
tivity determined. Finally, mean and standard deviation were
determined of the data obtained from five experiments.
Tissue autoradiography and morphometric analyses
The cortical biopsy tissues were minced into 1 mm3 pieces,
immersed in an aldehyde fixative, post-fixed in osmium tetrox-
ide, dehydrated in graded series of ethanol and propylene oxide
and embedded in EPON [36]. Thick (0.5 pm) as well as thin (60
nm) sections were prepared and processed for respective light
and electron microscopic autoradiographies as detailed in our
previous publications [30, 36]. The morphometric analyses
were carried out on EM autoradiograms only. Thirty-five mi-
crographs from each group were taken and printed to a final
magnification of x 5,000. Each micrograph included capillary
loops, mesangium and all the three cell types of the glomerulus.
Accordingly, four compartments were defined, that is, epithe-
hum, endothelium, mesangium and the glomerular basement
membrane (GBM). The mesangium included both the extracel-
lular matrix as well as the mesangial cell. Separate compart-
ments for the mesangial cell and its matrix were not assigned
due to the inherent difficulties in accurately delineating the two
compartments since the matrix is interspersed among the cyto-
plasmic processes of the cell. The relative area of each corn-
With the efficiency of extraction >96%, the total incorpo-
rated radioactivities associated with proteoglycans/glycosami-
noglycans (PGs/GAGs) were 7.83 0.58 x l0 dpm/kidney and
6.49 0.73 x l0 dpmlml in the tissue and media fractions,
respectively (Table 1). With the IGF-l treatment the incorpo-
rated radioactivities increased in both the fractions in a dose
dependent manner. However, the increased synthesis in the
media fraction appeared to be relatively more as compared with
the tissue fraction. Such increases were observed at all concen-
trations (62.5 to 625 nglml) of IGF-1.
Characterization of glomerular proteoglycans and
glycosaminoglycans
All chromatographic procedures were carried out in triplicate
and representative elution profiles of extracted proteoglycans/
glycosaminoglycans (PGs/GAGs) are shown in Figure 1. In the
control, a major peak of radioactivity (peak A) with Kay = 0.24
(Mr = 150,000 to 200,000, intact PGs) and a smaller shoulder
peak (peak B) with Kay = 0.48 (Mr 20 to 30,000, GAG chains)
were observed. Respective treatments of PGs/GAGs with hep-
aritinase and chondroitinase-ABC released —93% and —7% of
the radioactivities into the Vt fractions (Fig. 1A), indicating
thereby that the predominant de novo synthesized PGs/GAGs
were made up of heparan sulfate-proteoglycan (HS-PG). The
amount of chondroitin/dermatan sulfate proteoglycans (CSIDS-
PG) in peaks A and B were in proportion to the total incorpo-
rated radioactivity included in individual peaks.
The PGs/GAGs from kidneys exposed to IGF-1 showed
elution profiles similar to the control but containing relatively
more incorporated radioactivities (Fig. 1B). The results of the
treatment with heparitinase and chondroitinase-ABC revealed
an increase in the de novo synthesis of HS-PG as well as that of
CS/DS-PG. Although there was an increase in the total incor-
porated radioactivity associated with proteoglycans, the
amount associated with CS/DS-PG was disproportionately
higher (Fig. 2). The relatively higher increase in the synthesis of
CS/DS-PG was also seen at all concentrations of IGF-l used
(Fig. 2). A significant increase of three to fourfold in the
synthesis of CS/DS-PG was noted at a concentration of 625
ng/ml. Finally, the increase in the CS/DS-PG associated radio-
activity was observed in both the peaks eluted from Sepharose
CL-6B column, that is, peaks A and B. By DEAE-Sephacel
chromatography, no differences in the elution profiles were
observed between the control and IGF-l-treated groups.
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Alkaline treatment of the extracted PGs/GAGs resulted in the
release of GAG chains from the intact PGs and appeared as a
single peak of radioactivity and Kay shifted from 0.24 to 0.48
(Fig. 3). In these GAG chains, the proportion of HS and CSIDS
were similar to those noted in the intact PGs. However, a higher
proportion of CS/DS was observed in the IGF group (figure not
included).
Characterization of media proteoglycans/glycosaminoglycans
In the control, the elution profiles of media PGs/GAGs (Fig.
4A) revealed two peaks of radioactivity with Kay = 0.24 (peak
A) and 0,48 (peak B) by Sepharose CL-6B chromatography.
Most of the radioactivity was associated with peak B which
contained the GAG chains. Treatment with heparitinase and
chondroitinase-ABC released -90% and -10% of the radio-
activities into the Vt fractions, respectively. The radioactivities
released into the Vt fractions were proportionate to the total
radioactivities included in peaks A and B. The PGs/GAGs from
IGF- 1 exposed kidneys had elution profiles similar to that of the
control, but contained higher amounts of incorporated radio-
activities (Fig. 4B). The accentuation of peak B suggested an
increase in the synthesis of GAG chains or accelerated degra-
dation of de novo synthesized intact proteoglycans. Further-
more, the percentage of CS/DS-PG in the media fraction
increased in a dose dependent manner with increasing concen-
trations of IGF-1 and were comparable to values in tissue
fractions. DEAE-Sephacel chromatography revealed certain
differences between the control and experimental groups. The
PGs/GAGs of the control group eluted between 0.4 and 0.6 M
NaC1, whereas those of the IGF-1-treated group eluted between
0.35 and 0.55 M NaC1 of the salt gradient with a left shoulder
peak (Fig. 5).
Morphologic and autoradiographic studies
General morphologic features of glomerular epithelium,
endothelium, mesangium and of the extracellular matrices were
well preserved in both the groups. No discernible morphologi-
cal alterations were observed in the intracellular organelles of
the kidneys exposed to IGF-l. Also, the various cell types of
the glomerulus remained adherent to the extracellular matrices.
Light microscopic autoradiograms of the kidneys perfused
with t35S]-sulfate revealed an increase in silver grains associ-
ated with cellular as well as extracellular components of the
glomerulus (Fig. 6 A vs. B). The increase in the autoradio-
graphic grains was more obvious in the mesangial regions. Also,
the number of autoradiographic grains appeared to increase
more in the mesangial regions with exposure to higher concen-
tration of IGF-1 (Fig. 6 B vs. C vs. D). These differences were
more apparent by electron microscopic autoradiography. A
remarkable increase in the autoradiographic grains overlying
the GBM and mesangium was observed (Fig. 7 A vs. B). Some
increase was also observed over the epithelial and endothelial
compartments. The autoradiographic grains were mostly local-
ized over the Golgi-saccules of various cell types of the glomer-
ulus—the site where sulfation of the proteoglycans occurs.
Morphometric analyses of electron microscopic autoradio-
grams revealed an almost threefold higher grain density in the
mesangial compartment of the kidneys exposed to IGF- 1 as
compared to the control (Table 2). The increase in the grain
density over the GBM and endothelial compartments was
relatively less. The epithelial compartment exhibited an in-
crease of 25 to 30% in the grain density (Table 2).
Experiments with [35S]-methionine
Light microscopic autoradiograms revealed a mild to moder-
ate generalized increase in the silver grains overlying the
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various compartments of the glomeruli from kidneys exposed to
IGF-1 (Fig. 8 A vs. B). By electron microscopic autoradiogra-
phy, no appreciable differences were observed in the grains
overlying the epithelial, endothelial and the GBM compart-
A
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Vo vt
Fig. 4. Sepharose CL-6B chromatograms of
media PGs/GAGs from control (A) and IGF-
treated kidneys (B), before (original; —0—)
and after treat,nents with heparitinase (-.-D-.-)
and chondroitinase-ABC (C-ABC: ——-).
ments (Fig. 8 C vs. D). However, a notable increase was
observed in the mesangial compartment of the kidneys exposed
to IGF-1 as compared to the control. The grain density analyses
confirmed a selective increase in the incorporation of [35S]-
methionine associated radioactivity over the mesangial com-
partment of the glomeruli of the IGF-l group (Table 2). Never-
theless, the grain density of the mesangial compartment asso-
ciated with [3Sj-methionine was much less compared to that of
[35S]-sulfate. The biochemical studies further substantiated the
data of autoradiographic studies. A slight increase in the
incorporation of [35SJ-methionine into both the tissue and media
fractions was observed in IGF-l-treated kidneys (Table 3).
However, the increase in [35S]-methionine incorporation was
noticeably less compared to [35Sjsulfate with the exposure to
comparable amounts of IGF (Table 4).
Discussion
The results of this investigation indicate that IGF-l stimulates
a generalized de novo synthesis of proteins, more so of the
proteoglycans, and especially that of chondroitin/dermatan
0
C
a)0C0
C.)
a)z
sulfate. The increased synthesis of the latter may be attributable
to the stimulatory effect of IF-i on the mesangial cells of the
renal glomerulus. Although the stimulation was seen in all the
cell types of the glomerulus, the effect of IGF-l seems to be
predominantly targeted towards the mesangial cell.
The mesangial cell is located centrally in the renal glomerulus
and synthesizes a wide variety of glycoproteins, inflammatory
mediators and hormones, and exhibits autocrine and paracrine
functions [39, 40]. One of the glycoproteins which is exclusively
synthesized by the mesangial cell includes chondroitin sulfate-
proteoglycan (CS-PG) [30, 411. Incidentally, certain species of
CS-PGs synthesized by cultured mesangial cells have similar-
ities to decorin and biglycans [42, 43]. In any event, the
increased synthesis of CS/DS-PG observed here may be reflec-
tive of the enhanced biosynthetic activity of the mesangial cell
under the influence of IGF-l. Also, following IGF-l stimulation
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Fig. 5. DEAE-Sephacel chromatograms of
media PGs/GAGs from control (A) and IGF-l-
treated (B) groups. The media PGs/GAGs of
IGF-1 group elute at a relatively lower salt
concentration as compared to the control
(0.35—0.55 vs. 0.4—0.6 M NaCl), Symbols are:
(—0—) radioactivity; (—--_) NaC1.
Watanabe et al: IGF enhanced biosynthesis of PGs/GAGs 1269
Fig. 6. Light microscopic autoradiograms of[35SJsulfate-labelled glomerulifrom control (A) and IGF-1 -treated kidneys (B—D). A graded increase
in the concentration of grains over the mesangium (Me) is seen with increasing concentrations of IGF-1 (panel B = 62.5 ng/ml, C = 125 ng/ml, and
D = 625 ng/ml). Abbreviations are: Ep, epithelium; En, endothelium; C, capillary; US, urinary space. )< 800.
Table 2. Tissue autoradiographic grain density of various glomerular compartments
Epithelium Endothelium Mesangium' GBM
Sulfate
Control 0.66 0.21 0.71 0.34 0.74 0.30 1.48 0.41
IGF 125 nglml
IGF 375 nglml
IGF 625 nglml
0.68 0.19
0.81 0.20"
0.88 035b
0.85 0.31
1.01 0.25"
1.27 039b
1.28 0.26
1.87 0.29e
2.29 0.37c
2.25
2.45
2.81
038b
0•45b
Methionine
Control 2.38 0.49 1.94 0.31 2.03 0.41 4.10 0.57
IGF 375 nglml 2.68 0.46 2.50 0.51 3.29 0.51" 4.83 0.59
Thirty-five samples were used per variable for morphometric analyses.
Mesangium includes extracellular matrix as well as the mesangial cell
b P < 0.01
P < 0.001
o
>
4t
 
r.
!r.
tr 
—
 
.
t 1
 ¶ 
rn
 
.
.
 
-
 
.
 
-
.
 %
: 
_
_
_
 
C)
 
I 
-
 
•
 
1 
•
 
(• 
.
 
•
 
•
t 
•
. 
-
 
•
 
•
•
 
•
 4-
. I.. 
•
 
;q
tt•
 ,
 
9 
•
 
; 
1270 Watanabe et at: JGF enhanced biosynthesis of PGs/GAGs
Fig. 7. Electron microscopic autoradiograms of[35S]sulfate-lobelled glomerulifrom control (A) and IGF-I -treated kidneys (B). A notable increase
in the concentration of autoradiographic grains (arrows) overlying the mesangium (Me) is observed with the treatment of IGF-1 (625 ng/ml).
Abbreviations are: Ep, epitheliuin; En, endothelium; C, capillary; US, urinary space. )< 9,000.
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Fig. 8. Light (A and B) and electron (C and D) microscopic autoradiograms of [35 SJmethionine-labelled glomeruli from control (panels A and C)
and IGF-1 -treated (panels B and D) kidneys. A generalized increase in the concentration of autoradiographic grains (arrows) is observed with the
treatment of IGF-1 (375 ng/ml), and is more so over the mesangial (Me) regions. Abbreviations are: Ep, epithelium; En, endothelium; C, capillary;
US, urinary space. A and B x 800; C and D >< 3,000.
the three to fourfold increase in the autoradiographic grain
density (Table 2) indicative of de novo sulfated glycoprotein
synthesis suggests somewhat of a selective responsiveness of
the mesangial cell in a milieu where "all" the cell types of the
glomerulus are "equally" exposed to IGF-l. The effect of
IGF-l most likely occurs via receptor-mediated mechanisms. In
this regard, the receptors for insulin and insulin like growth
factors have been reported in isolated glomeruli [7, 44]. Fur-
thermore, receptors for IGF-l have been demonstrated on
cultured mesangial cells [8—10], whereas their presence on the
other cell types of glomerulus is unknown.
Via receptor-mediated mechanisms, the mesangial cells re-
spond to various hormones or growth factors, for example,
TGF-/3 and IGF. TGF-j3 has been shown to modulate the
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Table 3. [35S]-methionine associated radioactivity in tissue and media
fractionsa
Control IGF- 1 -treatedt'
Media 2.41 0,11 X 106(N 5) dpm/ml
Glomerular 4.37 0.23 x 108(N 5) dpm/kidney
___________
a The IGF concentration in the perfusion medium was 375 ng/ml
t' P < 0.05
functions of mesangial cells and thus play an important role in
the proliferative form of experimental glomerulonephritis and
glomeruloselerosis [42, 431. Along these lines, it is conceivable
that the biosynthetic functions of the mesangial cells can be
modulated by the high concentration of IGF-l in the serum in
diabetes via receptor-mediated mechanism [45]. By this mech-
anism, sustained high serum levels of IGF-l in vivo could result
in glomerular hypertrophy and a generalized increase in the
synthesis of various extracellular matrix proteins in the mesan-
gium. Such a generalized effect on protein synthesis was noted
in our present ex vivo studies, where some increase in the
incorporation of [35Sj-methionine was observed following a
short exposure (9 hr) to IGF-l. With comparable doses of
IGF-1, PG synthesis determined by [35SJ-sulfate labeling was
proportionately greater than total protein synthesis ascertained
by [35S]-methionine labeling (Table 4). This suggests that IGF-l
had a greater or more selective effect in stimulating the PG's
biosynthesis.
With respect to diabetes, several investigators have reported
a decreased de novo synthesis of proteoglycans in late stage
nephropathy [21—24]. In the late stage of diabetes, there is an
excessive accumulation of extracellular matrix and consequen-
tial mechanical compression of mesangial cells, which expect-
edly would interfere with their biosynthetic functions. This may
account for decreased de novo synthesis of PGs. Also, there is
growing evidence that sustained hyperglycemia itself inhibits
the biosynthesis of PGs [46]. Finally, the decreased de novo
biosynthesis of PGs has been investigated mostly in the strep-
tozotocin-induced diabetic model in which low, rather than
high, levels of IGF in the serum were detected [47, 48]. Thus,
the decreased biosynthesis of PGs in later stages of diabetes
may be multifactorial in origin.
Altered biosynthesis of any constitutive matrix glycoprotein
would disrupt its interactions with other matrix components,
and result in defective assemblage and organization of extracel-
lular matrix [49, 50]. An abnormal matrix may also form if
defective macromolecules are not retained on the cell surface in
order to mediate proper cell-matrix interactions but are released
into the extracellular compartment [49, 501. In this study IGF-l
also induced the following abnormalities in the synthesis of
proteoglycans: an increased number of GAG-chains were re-
leased into the media fraction, and PGs/GAGs in the media
exhibited a lower charge-density (0.35 to 0.55 vs. 0.4 to 0.6 M,
Fig. 5). The increased number of GAG chains in the media
could be due to augmented synthesis and/or enhanced turnover
(synthesis/degradation) of the proteoglycans under the influ-
ence of IGF-1. Persistence of these biochemical abnormalities
over a "prolonged period" could also contribute to defective
assemblane and organization of various matrix glycoproteins,
Table 4. Relative percentage increase of [35S]-methionine and lS]-
sulfate associated incorporated radioactivity with exposure to the
same concentration of IGF
Fractions [35S1-mcthionine [35S]-sulfatc
Glomerular
N=5)
Media(N 5)
_______ _______________
The IGF concentration used in the perfusion medium was 375 nglml
resulting in the formation of abnormal extracellular matrices.
Also, biosynthetic abnormalities in the proteoglycans, espe-
cially those present on the cell surfaces, may perturb the
cell-matrix interactions which ultimately would lead to a com-
promise in the filtration functions of the capillaries during the
later stages of diabetes [401.
In summary, IGF-l induces alterations in the de novo syn-
thesis of proteoglycans, in particular that of the chondroitin/
dermatan sulfate, by differentially affecting the biosynthetic
functions of the mesangial cell of the renal glomerulus. These
IGF- 1 induced biochemical changes may have a role in the
pathogenesis of the initial stages of diabetic nephropathy.
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